iPSC Regenerative Medicine
【Ophthalmology Area】
| Development Code |
Indication |
Market |
Pre-clinical test |
Clinical test |
Apply-approve |
On the Market |
Progress Status |
| HLCR011 |
Wet AMD |
Japan |
|
|
|
|
Joint development with Sumitomo Dainippon Pharma
Undergoing preparation for clinical trial |
| Development Code |
Indication |
Market |
Pre-clinical test |
Phase I Trial |
Phase II Trial |
Phase III Trial |
Apply-approve |
On the Market |
Progress Status |
| HLCR012 |
Dry AMD |
US
EU |
|
|
|
|
|
|
CRADA with NEI |
【Liver Disease】
| Development Code |
Indication |
Market |
Pre-clinical test |
Clinical test |
Apply-approve |
On the Market |
Progress Status |
| HLCL041 |
Metabolic Liver Disease |
Japan |
|
|
|
|
Joint research with Yokohama City University |
About iPSC Regenerative Medicine
Somatic Stem Cell Regenerative Medicine
| Development Code |
Indication |
Market |
Pre-clinical test |
Clinical test |
Apply-approve |
On the Market |
Progress Status |
| HLCM051 |
Ischemic Stroke |
Japan |
|
|
|
|
Clinical trial (TREASURE study) ongoing |
| HLCM051 |
ARDS |
Japan |
|
|
|
|
Clinical trial (ONE-BRIDGE study) ongoing |
About Somatic Stem Cell Regenerative Medicine
